Consistent with the reduction in tumor size, SMYD3-deficient tumor tissues exhibited diminished proliferation (Ki67) and increased cell death (cleaved-Caspase-3), as revealed by immunohistochemical staining (Fig. 3E). This evidence concerns the gene SMYD3 and neoplasm.